NCT00104897 2013-06-26
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Malignant Melanoma
National Cancer Institute (NCI)
Phase 2 Completed
Clinical Trials
3 trialsNCT00087386 2013-04-10
Tanespimycin in Treating Patients With Stage III-IV Melanoma
National Cancer Institute (NCI)
Phase 2 Terminated
NCT00627419 2012-12-10
A Study Evaluating the Safety and Antitumor Activity of IPI-504, in Patients With Metastatic Melanoma
Infinity Pharmaceuticals, Inc.
Phase 2 Terminated